Antithrombotic Strategies in Patients with Atrial Fibrillation Following Percutaneous Coronary Intervention: A Systemic Review and Network Meta-Analysis of Randomized Controlled Trials

Antithrombotic Strategies in Patients with Atrial Fibrillation Following Percutaneous Coronary Intervention: A Systemic Review and Network Meta-Analysis of Randomized Controlled Trials

Up to 10% of patients with atrial fibrillation (AF) undergo percutaneous coronary intervention (PCI). A systematic review and network meta-analysis were conducted by searching PubMed, Embase, and the Cochrane database of systematic reviews for randomized control trials that studied the safety and ef...

Full description

Bibliographic Details
Main Authors:	Su-Kiat Chua, Lung-Ching Chen, Kou-Gi Shyu, Jun-Jack Cheng, Huei-Fong Hung, Chiung-Zuan Chiu, Chiu-Mei Lin
Format:	Article
Language:	English
Published:	MDPI AG 2020-04-01
Series:	Journal of Clinical Medicine
Subjects:	Atrial ﬁbrillation antithrombotic therapy percutaneous coronary intervention dual anti-thrombotic therapy triple antithrombotic therapy
Online Access:	https://www.mdpi.com/2077-0383/9/4/1062

Similar Items

Safety and efficacy of dual versus triple antithrombotic therapy in Patients with atrial fibrillation undergoing percutaneous coronary intervention: a meta-analysis
by: Abdelmoniem Moustafa, et al.
Published: (2020-10-01)

Antithrombotic therapy in patients with atrial fibrillation and coronary artery disease
by: Abdelmoniem Moustafa, et al.
Published: (2019-10-01)

Analysis of antithrombotic therapy of atrial fibrillation in international and Russian registries
by: O. V. Reshetko, et al.
Published: (2019-08-01)

Dual-Pathway Antithrombotic Therapy in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention in Stable Coronary Artery Disease: A Single-Center, Single-Operator, Retrospective Cohort Study
by: Lukas Andreas Heger, et al.
Published: (2020-09-01)

ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONS
by: V. A. Sulimov
Published: (2016-01-01)

Changes in Antithrombotic Therapy of Atrial Fibrillation in the Hospital in 2011-2012 and 2016-2017 (Pharmacoepidemiological Analysis)
by: O. V. Reshetko, et al.
Published: (2020-11-01)

The quality of prior antithrombotic therapy and the severity of ischemic stroke in atrial fibrillation
by: L. A. Geraskina, et al.
Published: (2020-10-01)

ANTITHROMBOTIC THERAPY IN NONVALVULAR ATRIAL FIBRILLATION: PROBLEMS AND PROSPECTS
by: A. Y. Rychkov, et al.
Published: (2016-01-01)

The Management of Combined Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Particularly Complex Challenge, Especially in the Elderly
by: Leonardo Bencivenga, et al.
Published: (2018-07-01)

Antithrombotic therapy in very elderly patients with atrial fibrillation: Is it enough to assess thromboembolic risk?
by: Yutao Guo, et al.
Published: (2010-05-01)

Comparative Analysis of Antithrombotic Therapy in In-Patients with Atrial Fibrillation
by: V. I. Petrov, et al.
Published: (2019-03-01)

Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome
by: Wilbert Bor, et al.
Published: (2020-06-01)

Anticoagulation in patients with atrial fibrillation and coronary artery disease
by: Fahad Abdullah Alkindi, et al.
Published: (2020-01-01)

The antithrombotic therapy of atrial fibrillation in patients with coronary heart disease
by: Olga L. Bockeria, et al.
Published: (2018-11-01)

Modern strategy of antithrombotic therapy in patients with coronary artery disease and atrial fibrillation after percutaneous coronary intervention
by: Yu. A. Karpov
Published: (2019-12-01)

ANALYSIS OF ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT ATRIAL FIBRILLATION (PHARMACOEPIDEMIOLOGY STUDY)
by: V. I. Petrov, et al.
Published: (2015-09-01)

RIVAROXABAN IN THE PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH ATRIAL FIBRILLATION
by: M. Yu. Gilyarov
Published: (2015-12-01)

Thrombotic and hemorrhagic complications in atrial fibrillation patients, undergoing elective percutaneous coronary intervention
by: E N Krivosheeva, et al.
Published: (2019-09-01)

THE RISK OF BLEEDINGS IN PATIENTS WITH ATRIAL FIBRILLATION DURING ANTICOAGULANT THERAPY
by: M. Yu. Gilyarov
Published: (2015-12-01)

Optimisation of oral anticoagulants for patients with atrial fibrillation within 12 months after percutaneous coronary intervention: A meta-analysis and systematic review
by: Shuo Wang, et al.
Published: (2021-10-01)

PROSPECTS FOR THE TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION
by: V. A. Sulimov, et al.
Published: (2016-01-01)

ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: RECENT APPROACHES AND NEAR PERSPECTIVES
by: Ya. P. Dovgalevskiy, et al.
Published: (2016-01-01)

AGE AND EFFECTIVENESS AND SAFETY OF VARIOUS ANTITHROMBOTIC THERAPY VARIANTS IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION
by: V. I. Shevelev, et al.
Published: (2013-02-01)

THE EVALUATION OF ANTITHROMBOTIC TREATMENT PRESCRIPTION DYNAMICS IN PATIENTS WITH ATRIAL FIBRILLATION BY THE DATA OF PROFILE REGISTRY
by: S. Yu. Martsevich, et al.
Published: (2015-02-01)

Management of antithrombotic therapy in patients with atrial fibrillation and acute coronary syndromes
by: Călin Pop, et al.
Published: (2021-09-01)

APPROACHES TO ANTITHROMBOTIC THERAPY IN ELDERLY PATIENTS WITH ATRIAL FIBRILLATION
by: E. A. Ushkalova, et al.
Published: (2017-05-01)

RISK OF THROMBOEMBOLIC COMPLICATIONS AND ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT AND RECURRENT ATRIAL FIBRILLATION IN REAL CLINICAL PRACTICE
by: I. V. Grajfer, et al.
Published: (2015-12-01)

Fact-finding survey of antithrombotic treatment for prevention of cerebral and systemic thromboembolism in patients with non-valvular atrial fibrillation in 9 countries of the Asia-Pacific region
by: Satoshi Ogawa, et al.
Published: (2012-02-01)

The safety of antithrombotic therapy in patients with cerebral microbleeds and cardiogenic cerebral embolism due to nonvalvular atrial fibrillation
by: Jiayu Wang, et al.
Published: (2019-04-01)

Changes in prescribing antithrombotic therapy in patients with atrial fibrillation and myocardial infarction in 2016-2019
by: K. G. Pereverzeva, et al.
Published: (2020-08-01)

Anticoagulation management in non-valvular atrial fibrillation in rural and remote Crete. A single-center study from the region of Sitia
by: Panteleimon E. Papakonstantinou, et al.
Published: (2016-07-01)

Current Use of Oral Anticoagulants and Prognostic Analysis in Patients with Atrial Fibrillation Undergoing Coronary Stenting
by: Heng-Bo Zhai, et al.
Published: (2017-01-01)

Triple Antithrombotic Therapy in Patients with Acute Coronary Syndrome and Atrial Fibrillation – Balancing Risks and Benefits
by: Alexandru DEACONU, et al.
Published: (2021-03-01)

Prior Antithrombotic Therapy Is Associated With Cerebral Microbleeds in Ischemic Stroke Patients With Atrial Fibrillation and/or Rheumatic Heart Disease
by: Yajun Cheng, et al.
Published: (2019-01-01)

Role of Different Antithrombotic Regimens after Percutaneous Left Atrial Appendage Occlusion: A Large Single Center Experience
by: Patrizio Mazzone, et al.
Published: (2021-05-01)

Does antithrombotic therapy improve survival with colorectal cancer?
by: Kodai Takahashi, et al.
Published: (2017-08-01)

Antithrombotic alternatives for stroke prevention in atrial fibrillation: critical differences and remaining questions
by: James S Kalus
Published: (2013-04-01)

PATIENTS WITH ATRIAL FIBRILLATION AND ISCHEMIC HEART DISEASE: HOSPITALIZATION STRUCTURE AND ANTITHROMBOTIC THERAPY (RECVASA AF-KURSK REGISTRY)
by: V. P. Mikhin, et al.
Published: (2017-05-01)

Ischemic stroke and antithrombotic therapy: key aspects
by: M. Yu. Maksimova, et al.
Published: (2019-12-01)

ANTITHROMBOTIC PROPHYLAXIS RECURRENT PREECLAMPSIA IN PATIENTS WITH THROMBOPHILIA
by: E. V. Zhuravleva, et al.
Published: (2016-06-01)